nih guide - vol. 16, no. 10 - march 13, 1987 · 2014. 10. 3. · availability of retinal...

12
NOTICE OF MAILING CHANGE 0 Check here ifyou wish to discontinue receiving this publication 0 Check here ifyour addresshas changed and you wish to con- tinue receiving this publication Make corrections below and mail this page to: NIH Guide Distribution Center National Institutes of Health Room B3BE07, Building 31 Bethesda, Maryland 20892 Postage & Fees Paid PHS/NIH/OD Permit No. G-291 US. DEPARTMENT OF HENTH AND HUMAN SERVICES OFFICIAL BL'SINESS Penalty for Private be, $300 The NIH Guide announces scientific initiatives and provides poliq and administrative information to indivi~ duals and organizationswho need to be kept informed ofopponunities, requiremeno. and changes in extn mural progams administered by the * q4 National Institutes of Health. VOL. 16, NO. 10, MARCH 13, 1987

Upload: others

Post on 08-Oct-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: NIH Guide - Vol. 16, No. 10 - March 13, 1987 · 2014. 10. 3. · AVAILABILITY OF RETINAL DEGENERATION MUTANTS P.T. 34; K.W. 0780000, 1002002, 0780020 bd National Eye Institute The

NOTICE OF MAILING CHANGE 0 Check here i fyou wish to

discont inue receiving this publication

0 Check here ifyour addresshas changed and you wish to con­tinue receiving this publication Make corrections below and mail this page to:

NIH Guide Distribution Center National Institutes of Health Room B3BE07, Building 31 Bethesda, Maryland 20892

Postage & Fees Paid PHS/NIH/OD

Permit No. G-291

US. DEPARTMENT OF HENTH AND HUMAN SERVICES

OFFICIAL BL'SINESS Penalty for Private b e , $300

The NIH Guide announces scientific initiatives and provides poliq and administrative information to indivi~ duals and organizationswho need t o

be kept informed ofopponunities, requiremeno. and changes in extn mural progams administered by the* q4 National Institutes o f Health.

VOL. 16, NO. 10, MARCH 13, 1987

Page 2: NIH Guide - Vol. 16, No. 10 - March 13, 1987 · 2014. 10. 3. · AVAILABILITY OF RETINAL DEGENERATION MUTANTS P.T. 34; K.W. 0780000, 1002002, 0780020 bd National Eye Institute The

Vol. 16, No. 10, March 13, 1987

NOTICG

A V A I U B I L I T Y OF RETINAL DEGENERATION MVTANTS .................................. 1 National Eye I n s t i t u t e Index: EYE

AVAILABLE RESOURCES

DATED ANNOUNCEMENTS (RFPs AND RFAs AVAILABLE)

DROSOPHILA MUTAGENESIS TESTING (RFP). ......................................... 3 National I n s t i t u t e of Environmental Heal th Sciences Index: ENVIRONMENTAL HEALTH SCIENCES

CORONARY HEART DISEASE AND STROKE I N PEOPLE AGED 65 TO 84 YEARS - ECHOCARDIOGRAPHY R E A D I N G CENTER (RFP). ........................... 3

National Heart, Lung, and Blood I n s t i t u t e Index: HEART, LUNG, AND BLOOD

T R A I N I N G I N LABORATORY ANIMAL SCIENCE AND MEDICINE - ANIMAL RESOURCES PROGRAM. ..................................... 4

Divis ion of Research Resources Index: RESEARCH RESOURCES

EARLY DIAGNOSIS AND QUANTITATIVE ASSESSMENT OF PROSTATE ADENOCARCINOMA BY ULTRASONOGRAPHY (RFA).........................4

National Cancer I n s t i t u t e Index: CANCER

O N G O I NO PROGRAM ANN OUNCEMENTS

d' CEREBROVASCULAR DISEASE AND STROKE I N BLACKS AND OTHER MINORITIES.............5 National I n s t i t u t e of Neurological and Communicative

Disorders and St roke Index: NEUROLOGICAL AND COMMUNICATIVE DISORDERS AND STROKE

SHALL GRANT PROGRAM FOR PILOT PROJECTS............................,............7National Eye I n s t i t u t e Index: EYE

CENTERS FOR NEUROSCIENCE AND SCHIZOPHRENIA (CNSs) ............................. 8 National I n s t i t u t e of Mental Health Index: NATIONAL INSTITUTE OF MENTAL HEALTH

DEMENTIA ASSOCIATED WITH CEREBROVASCULAR DISEASE: ELUCIDATION OF MECHANISMS ............................................................ 9

National I n s t i t u t e of Neurological and Communicative Disorders and St roke

Index: NEUROLOGICAL AND COMMUNICATIVE DISORDERS AND STROKE

ERRATUM

INCLUSION OF WOMEN I N STUDY POPULATIONS....................................... 10 National I n s t i t u t e s of Health Alcohol, Drug Abuse, and Mental Heal th Adminis t ra t ion Index: ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH

NATIONAL INSTITUTES OF HEALTH

Page 3: NIH Guide - Vol. 16, No. 10 - March 13, 1987 · 2014. 10. 3. · AVAILABILITY OF RETINAL DEGENERATION MUTANTS P.T. 34; K.W. 0780000, 1002002, 0780020 bd National Eye Institute The

AVAILABILITY OF RETINAL DEGENERATION MUTANTS

P.T. 3 4 ; K.W. 0780000, 1002002, 0780020 bd

National Eye I n s t i t u t e

The Nat ional Eye I n s t i t u t e (NE11 suppor ts t h e breeding and t h e d i s t r i b u t i o n o f wel l -charac te r ized r e t i n a l degenerat ion mutants t o q u a l i f i e d i n v e s t i g a t o r s . Mutants (mice, r a t s , and dogs) and some l i m i t e d s e r v i c e s ( e . g . , t i s s u e p repa ra t ion ) are provided. There w i l l be no fee for ,an imals , t i s s u e s , o r s e r v i c e s , bu t a l l sh ippingcharges must be m e t by t h e i n v e s t i g a t o r . The NE1 program goal is t o accelerate t h e pace o f r e sea rch on R e t i n i t i s Pigmentosa and o t h e r r e t i n a l degenera t ive d i s o r d e r s and t o a t t r ac t new i n v e s t i g a t o r s t o t h e f i e l d . Some s p e c i f i c s and t h e name of t h e appropr i a t e person t o con tac t f o r complete information fo l low. NOTE: Guide format r e s t r i c t i o n s prec lude t h e use o f s u p e r s c r i p t symbols; g e n e t i c s u p e r s c r i p t symbols are p r i n t e d on t h e same l i n e as r e g u l a r t e x t , bu t are preceded by an a s t e r i s k ( X I .

MICE

Inbred l i n e s o f mice wi th i n h e r i t e d r e t i n a l degenera t ions or o t h e r v i s u a l systemd e f e c t s are a v a i l a b l e from two sources , The Div is ion o f Neuroscience, Chi ldren ' s Hospi ta l (Boston) and Erasmus Univers i ty (Rotterdam).

MICE (BOSTON COLONY) The fol lowing t a b l e l ists t h e mutant s t r a i n s t h a t are a l r eadye s t a b l i s h e d and t h o s e t h a t w i l l become a v a i l a b l e s h o r t l y . Addi t iona l hypopigmentation mutants and a l l e l e s w i l l be added i f a demand for them is expressed.

N a m e Symbol S t r a i n

Avai lab le mutant s t r a i n s :

Albino cX2J C57BLI6J-cX2J Nervous n r BALBI cGr-nr Pearl Pe C57BLI6J-pePearl (wild t y p e - r e v e r t . ) peXt2P C57BLI6J-peXt2PPink-eyed uns t ab le pnun C57BLI6J-p Xun

\/ Purkin je c e l l degenerat ion pcd BALBIcBy-pcdRe t ina l degenera t ion r d C 3 H I H e J Ruby-eye-2 ru-2XJ C57BLI6J-ru-2XJ F1ecked T(X; 7 11C t DpIX cX2JIDf (Cat tanach ' s t r a n s l o c a t i o n )

Addi t iona l s t r a i n s t o be made a v a i l a b l e a t a l a t e r da t e r

Cribiform degenera t ion c r i DBM2J-cri Purkin je c e l l degenera t ion pcd C57BL/6J-pcd

Purkin je c e l l degenerat ion pcdX2J SMIJ-pcdX2JPurkin je c e l l degenera t ion C57BLI6J-pcdX2JPurkin je c e l l degenerat ion pcdXSid C57BLI6J-pcdXSidRet ina l degenerat ion r d C57BLI6J-rd l e Gus-sXh V i t i l i g o v i t C57BLI6J-vit

For f u r t h e r information, con tac t :

D r . Richard L . Sidman or Dr. Paul Neumann Divis ion o f Neuroscience Chi ldren ' s Hospi ta l 300 Longwood Avenue Boston, MA 02115 Telephone: (617) 735-6077 or -6076

MICE (ROTTERDAM COLONY)

Ret ina l degenerat ion, rd , and Re t ina l degenera t ion slow, rds , are a v a i l a b l e s e p a r a t e l y and as a double mutant on t h e pigmented C3H-rdXt and a l b i n o BALBIc congenic l i n e s .

1

Page 4: NIH Guide - Vol. 16, No. 10 - March 13, 1987 · 2014. 10. 3. · AVAILABILITY OF RETINAL DEGENERATION MUTANTS P.T. 34; K.W. 0780000, 1002002, 0780020 bd National Eye Institute The

--

For f u r t h e r information, c o n t a c t :

D r . Somes C . Sanyal Department o f Anatomy I Erasmus Un ive r s i ty Postbox 1738 3000 DR Rotterdam, The Netherlands Telephoner 01-4635182

RATS

Royal Col lege of Surgeons (RCS) rats with i n h e r i t e d r e t i n a l dystrophy and s e v e r a l congenic s t r a i n s of RCS animals are a v a i l a b l e as fol lowsi

RCS Pink-eyed dys t roph ic s t r a i n RCS-rdyX+ Pink-eyed normal ( c o n t r o l ) s t r a i n RCS-pX+ Black-eyed dys t roph ic s t r a i n RCS-rdyX+pX+ Black-eyed normal ( c o n t r o l ) s t r a i n RCS-c Albino dys t roph ic s t r a i n

Congenic F344-c/+ rats are a l s o a v a i l a b l e . This s t r a i n provides g e n e t i c a l l y similar a l b i n o and hooded (b l ack pigmented) l i t termate animals with normal r e t i n a s . These animals are optimal f o r t h e s tudy o f pigmentation d i f f e r e n c e s i n such r e s e a r c h areas as l ight- induced r e t i n a l degenerat ion or ganglion c e l l axonal guidance mechanisms.

For f u r t h e r information, c o n t a c t :

D r . Matthew M . L a V a i l or M s . Nancy Lawson Unive r s i ty o f C a l i f o r n i a , San Francisco Department o f Anatomy, Box 0452 San Francisco, CA 94143 Telephone: (415) 476-4234

DOGS

Animals and t i s s u e s are a v a i l a b l e on a competetive b a s i s . A b r i e f r e sea rch p r o t o c o lw i l l be requested and reviewed f o r s c i e n t i f i c merit by an independent advisorycommittee. Approved i n v e s t i g a t o r s may e l e c t t o have dogs shipped t o t h e i r i n s t i t u t i o n or t o have o c u l a r and/or nonocular t i s s u e s c o l l e c t e d and shipped from t h e colony.

Miniature poodles e i t h e r a f f e c t e d with, heterozygous f o r , or homozygous normal for progres s ive rod cone degenerat ion ( p r c d ) . The r e t i n a l degenerat ion i n prcd-affected m . poodles is a l a t e onse t d i s o r d e r , c h a r a c t e r i z e d by a abnormally low rod o u t e r segment (ROS) renewal ra te .

I r i s h setters e i t h e r a f f e c t e d with, heterozygous f o r , or homozygous normal f o r rod cone d y s p l a s i a ( r c d l ) . The r e t i n a l degenerat ion i n r c d l - a f f e c t e d I r i s h set ters is an e a r l y onse t d i s o r d e r , c h a r a c t e r i z e d by a r r e s t e d development of ROS and abnormal r e t i n a l c y c l i c GMP metabolism.

Norwegian elkhounds e i t h e r a f f e c t e d with or heterozygous f o r e a r l y r e t i n a l degenerat ion ( e r d ) . The colony is composed of c rossb red elkhound-beagles, de r ived from t h e o r i g i n a l purebred Norwegian elkhounds i n which t h e d i s e a s e e r d w a s first recognized. The r e t i n a l degenerat ion i n e rd -a f f ec t ed dogs is an e a r l y onse t d i s o r d e r , c h a r a c t e r i z e d by abnormal development of rod inne r and o u t e r segments, and o f rod and cone s y n a p t i c t e r m i n a l s . R e t i n a l c y c l i c GMP metabolism is normal.

For f u r t h e r information, c o n t a c t :

D r . J ack A. McLaughlinNational Eye I n s t i t u t e Nat ional I n s t i t u t e s o f Heal th Building 31, Room 6A51 Bethesda, MD 20892 Telephone: (301) 496-5983

8

2

Page 5: NIH Guide - Vol. 16, No. 10 - March 13, 1987 · 2014. 10. 3. · AVAILABILITY OF RETINAL DEGENERATION MUTANTS P.T. 34; K.W. 0780000, 1002002, 0780020 bd National Eye Institute The

9A s V

DROSOPHILA MUTAGENESIS TESTING

RFP AVAILABLE: NIH-ES-87-02

k.& P.T. 34; K.W. 1002028, 0755010

Nat ional I n s t i t u t e o f Environmental Heal th Sciences

The Nat ional Toxicology Program, Nat ional I n s t i t u t e o f Environmental Heal th Sc iences (NIEHS), Nat ional I n s t i t u t e s o f Health, is s o l i c i t i n g q u a l i f i e d sources having t h e c a p a b i l i t y t o perform Drosphi la sex-l inked r e c e s s i v e l e t h a l and r e c i p r o c a lt r a n s l o c a t i o n a s says f o r d e t e c t i o n o f mutagenic chemicals. The success fu l con t r ac to r w i l l be r equ i r ed t o test approximately 40 chemicals, over a four-yearper iod , f o r mutagenici ty us ing t h e sex-l inked r e c e s s i v e l e t h a l t e s t and t h e r e c i p r o c a l t r a n s l o c a t i o n tes t i n Drosophila melano-gaster. Of fe ro r s should possessdemonstrated p ro f i c i ency and experience i n t h e use o f Drosophila f o r d e t e c t i o n of chemically-induced mutat ions. The es t imated i ssuance d a t e o f RFP NIH-ES-87-02 is March 16, 1987, and responses w i l l be due t o be rece ived by t h e Contract S p e c i a l i s t no l a t e r than May 15, 1987.

Requests should r e fe rence RFP NIH-ES-87-02 and should be forwarded t o :

Nat ional I n s t i t u t e o f Environmental Heal th Sciences Contrac ts Management Office, OAM Attn : M s . Dorothy G . W i l l i a m s 4310 South M i a m i Boulevard P.O. Box 12874 Research Tr i ang le Park, North Caro l ina 27709

CORONARY HEART DISEASE AND STROKE I N PEOPLE AGED 65 TO 84 YEARS -ECHOCARDIOGRAPHY READING CENTER

RFP AVAILABLE: NIH-NHLBI-HC-87-07

P.T. 34; K.W. 0715040, 0706030

%d National Heart, Lung, and Blood I n s t i t u t e

The Epidemiology and Biometry Research Program, DECA, NHLBI, seeks an echocardiography reading c e n t e r f o r a p r o j e c t i n which four f i e l d c e n t e r s w i l l r e c r u i t , examine, and fol low a t o t a l o f 5000 men and women (1250 i n each c e n t e r ) aged 65 t o 84 yea r s a t t h e b a s e l i n e examination i n a prospec t ive s tudy o f coronary h e a r t d i s e a s e s and s t r o k e . The echocardiography reading c e n t e r w i l l develop a pro toco l f o r c o l l e c t i o n of echocardiography d a t a a t t h e f o u r f i e l d c e n t e r s and perform p r e c i s e measures o f c a r d i a c s t r u c t u r e and func t ion from t h e echocardiograe d a t a c o l l e c t e d .

I n a d d i t i o n t o t h i s RFP f o r t h e Echocardiography Reading Center , separate RFPs will be announced as they become a v a i l a b l e f o r r ( 1 ) t h e Lip id and Hemostasis Center andr (2 ) t h e Ultrasound Reading Center . RFPs f o r t h e F i e l d Centers and Coordinat ing Center have a l r eady been announced.

RFP NHLBI-HC-87-07 for t h e Echocardiography Reading Center w i l l be a v a i l a b l e on o r about Apr i l 24, 1987, with proposa ls due June 29, 1987. One award is a n t i c i p a t e d . Your w r i t t e n r eques t should inc lude t h r e e mai l ing l a b e l s , se l f -addressed , and must c i t e RFP No. NHLBI-HC-87-07.

Requests f o r cop ie s o f t h e RFP should be s e n t t o :

Bet ty Nordan Contrac t ing Officer f o r Epidemiology and Biometry Research Program,ECA Cont rac ts Sec t ion National Heart, Lung, & Blood I n s t i t u t e Federa l Bldg., Room 3C16 Bethesda, MD 20892

3

Page 6: NIH Guide - Vol. 16, No. 10 - March 13, 1987 · 2014. 10. 3. · AVAILABILITY OF RETINAL DEGENERATION MUTANTS P.T. 34; K.W. 0780000, 1002002, 0780020 bd National Eye Institute The

T R A I N I N G I N LABORATORY ANIMAL SCIENCE AND MEDICINE -WIMAL RESOURCES PROGW

P.T. 34; K.W. 0720005j 0201058j 0755020

Div i s ion o f Research Resources

Applicat ion Receipt Date: May 10 , 1987

The Div i s ion of Research Resources ( D R R ) has supported t r a i n i n g programs i n l a b o r a t o r y animal s c i ence and medicine s i n c e 1965. There are n ine a c t i v e i n s t i t u t i o n a l t r a i n i n g programs.

RESEARCH GOALS AND SCOPE

Addit ional new and supplemental t r a i n i n g a p p l i c a t i o n s are requested for programst h a t w i l l provide p o s t d o c t o r a l t r a i n i n g f o r v e t e r i n a r i a n s i n l a b o r a t o r y animal s c i ence and medicine. Proposals should provide for up t o t h r e e y e a r s of t r a i n i n gand inco rpora t e r e sea rch t r a i n i n g i n a r e a s r e l e v a n t t o l a b o r a t o r y animal s c i ence ,such as l a b o r a t o r y animal d i s e a s e s and development o f animal models.

ELIGIBILITY AND REVIEW

Any domestic p u b l i c or nonpro f i t i n s t i t u t i o n , o rgan iza t ion or a s s o c i a t i o n is e l i g i b l e t o apply. App l i ca t ions w i l l be r ece ived by t h e N I H D iv i s ion o f Research Grants on-PHS Form 6025-1 . Appl i ca t ions w i l l be reviewed by t h e Animal Resources Review Committee f o r s c i e n t i f i c merit, and t h e Nat ional Advisory Research Resources Council o f t h e DRR f o r program c o n s i d e r a t i o n s .

MECHANISM OF SUPPORT

Awards w i l l be as competi t ive i n s t i t u t i o n a l t r a i n i n g g r a n t s f o r p r o j e c t pe r iods upt o f i v e y e a r s . A l l p o l i c i e s and requirements which govern Nat ional Research Se rv ice A w a r d s apply t o this program.

INQUIRIES

Applicants are encouraged t o d i s c u s s t h e i r p l a n s and o b t a i n a d d i t i o n a l information from t h e Animal Resources Program.

D r . W i l l i a m I. Gay or D r . John E . Holman Animal Resources ProgramDivision o f Research Resources Building 31, Room 5B59 National I n s t i t u t e s o f Health Bethesda, MD 20892 Telephone: ( 3 0 1 ) 496-5175

EARLY DIAGNOSIS AND QUANTITATIVE ASSESSMENT OF PROSTATE ADENOCARCINOMA BY ULTRASONOGRAPHY

RFA AVAILABLE: 87-CA-20

P . T . 34; K.W. 0715035, 0706030, 0745020

National Cancer I n s t i t u t e

Applicat ion Receipt Date: June 15 , 1987

The Divis ion of Cancer Prevent ion and Control o f t h e Nat ional Cancer I n s t i t u t e ( N C I )through t h e Organ Systems Program, i n v i t e s r e sea rch g r a n t a p p l i c a t i o n s from o r g a n i z a t i o n s capable and i n t e r e s t e d i n p a r t i c i p a t i n g i n a network of c o l l a b o r a t i n gi n s t i t u t i o n s charged with c a r r y i n g out s t u d i e s on t h e e a r l y d i agnos i s and q u a n t i t a t i v e assessment o f p r o s t a t e adenocarcinoma.

OBJECTIVES AND SCOPE

Th i s Request f o r App l i ca t ions (RFA) w i l l be u t i l i z e d t o i n i t i a t e s t u d i e s which w i l l be implemented through a c o l l a b o r a t i o n among t h e s u c c e s s f u l a p p l i c a n t o r g a n i z a t i o n s .The N C I proposes t o encourage up t o f i v e e x i s t i n g p r o s t a t e r e sea rch l a b o r a t o r i e s or c l i n i c s with ul t rasonography c a p a b i l i t i e s t o assemble t h e e x p e r t i s e and p a t i e n t sneeded t o s tudy e a r l y d i agnos i s o f p r o s t a t e cance r . The main goal is t o determine t h e c a p a b i l i t y o f ul t rasonography used a lone or i n combination with b i o l o g i c a lmarkers t o diagnose e a r l y p r o s t a t e cancer , t o measure t h e volume of cancer t i s s u e and determine i ts p o t e n t i a l invasiveness , and t o measure t h e impact o f t h e s e procedures on s u r v i v a l by fol lowing p a t i e n t s over t i m e .

4

“ar

Page 7: NIH Guide - Vol. 16, No. 10 - March 13, 1987 · 2014. 10. 3. · AVAILABILITY OF RETINAL DEGENERATION MUTANTS P.T. 34; K.W. 0780000, 1002002, 0780020 bd National Eye Institute The

\d

k j

BACKGROUND

S t u d i e s have i n d i c a t e d t h a t when diagnosed e a r l y , and p r i o r t o c a p s u l a r invasion, t h e cu re ra te f o r p r o s t a t e cancer is p o t e n t i a l l y improved. I n a d d i t i o n , it has been r epor t ed t h a t tumor volume is a s s o c i a t e d with capacity t o metastasize. A t p re sen t , t h e r e is gene ra l consensus t h a t among imaging moda l i t i e s c u r r e n t l y a v a i l a b l e , ultrasonography o f f e r s t h e greatest p o t e n t i a l f o r e a r l y d i a g n o s i s and volume assessment of p r o s t a t e carcinoma. The a d d i t i o n o f known b i o l o g i c a l markers mayenhance t h e c a p a b i l i t y o f l a b o r a t o r i e s o r c l i n i c s with e x i s t i n g ul t rasonography c a p a b i l i t i e s are encouraged t o t a k e t h e l e a d e r s h i p i n response t o t h i s RFA. It is t h e i n t e n t of t h i s RFA t o i n i t i a t e network s t u d i e s among o r g a n i z a t i o n s f o r t h e purpose of e v a l u a t i n g ultrasonography i n diagnosing e a r l y p r o s t a t e cancer u s i n g uniform and s t anda rd ized approaches and t echn iques . A t t h e time o f submission, a c o r e o f q u a l i f i e d i n v e s t i g a t o r s , t e c h n i c a l e x p e r t i s e , p a t i e n t popu la t ions , and f a c i l i t i e s should e x i s t i n t h e a p p l i c a n t o rgan iza t ion and any proposed aff i l ia tes .

APPLICATION SUBMISSION AND REVIEW

A p o t e n t i a l a p p l i c a n t is encouraged, bu t is no t r equ i r ed , t o submit a le t te r o f i n t e n t , and is encouraged t o c o n s u l t with N C I s ta f f be fo re submit t ing. Letters o f i n t e n t are requested by A p r i l 17, 1987. The l e t t e r of i n t e n t w i l l n o t e n t e r i n t o t h e review o f an a p p l i c a t i o n submitted i n response t o t h i s RFA.

Appl i ca t ions responsive t o t h i s RFA w i l l be reviewed f o r s c i e n t i f i c merit by an a p p r o p r i a t e review group composed p r i m a r i l y o f non-Federal e x p e r t s and convened byt h e Div i s ion of Extramural A c t i v i t i e s , Nat ional Cancer I n s t i t u t e . Reviewers w i l l cons ide r each a p p l i c a t i o n i n terms o f i t s p r o j e c t e d r e sea rch p l a n s and proposedp l a n s f o r implementing network a c t i v i t i e s . This RFA announcement s o l i c i t a t i o n is f o r a s i n g l e competi t ion and has one s p e c i f i c dead l ine , June 15, 1987, f o r r e c e i p t of a p p l i c a t i o n s .

MECHANISM OF SUPPORT

The support mechanism f o r t h i s program w i l l be t h e N I H i n v e s t i g a t o r - i n i t i a t e d r e sea rch g r a n t ( R o l l . Awards may be made t o domestic non-profi t and p r o f i t o r g a n i z a t i o n s . An a p p l i c a n t o rgan iza t ion may apply for a pe r iod o f support of up t o t h r e e y e a r s . It is a n t i c i p a t e d t h a t up t o f i v e awards w i l l be made a t an annual t o t a l c o s t o f approximately $600,000. Although t h i s rogram is provided f o r i n t h e f i n a n c i a l p l a n s o f t h e Nat ional Cancer I n s t i t u t e ( N C I P , t h e award o f g r a n t s pursuant t o t h i s RFA is a l s o cont ingent upon t h e a v a i l a b i l i t y of funds for t h i s purpose. PHS g r a n t p o l i c i e s governing r e g u l a r r e s e a r c h p r o j e c t g r a n t s apply t o a p p l i c a t i o n s received i n RFA, p l e a s e c o n t a c t :

Andrew Chiarodo, Ph.D. Organ Systems Sec t ion Cancer Centers Branch Division o f Cancer Prevent ion and Control National Cancer I n s t i t u t e B l a i r Building, Room 717 Bethesda, Maryland 20892-4200

1R B

P.T. 34 , FF; K . W . 0715200, 0785055, 0411005, 0745020

National I n s t i t u t e of Neurological and Communicative Disorders and S t roke

The S t roke and Trauma Program (STP), Nat ional I n s t i t u t e o f Neurological and Communicative Disorders and S t roke (NINCDS), i n v i t e s a p p l i c a t i o n s f o r support of r e sea rch t h a t w i l l i n c r e a s e our knowledge and understanding o f cerebrovascular d i s e a s e i n Blacks and o t h e r m i n o r i t i e s .

BACKGROUND

According t o t h e Report o f t h e S e c r e t a r y ' s Task Force on Black and Minority Heal th (August 19851, t h e r e is a con t inu ing d i s p a r i t y i n t h e burden of d e a t h and i l l n e s s experienced by Blacks and o t h e r minori ty Americans compared with t h e popu la t ion as a whole. I n t h e United S t a t e s , s t r o k e is t h e t h i r d l e a d i n g cause o f dea th and a prime cause o f d i s a b i l i t y . A t least a h a l f m i l l i o n Americans each yea r s u f f e r an a c u t e s t r o k e . The o v e r a l l problem is even more imposing than annual incidence and

5

Page 8: NIH Guide - Vol. 16, No. 10 - March 13, 1987 · 2014. 10. 3. · AVAILABILITY OF RETINAL DEGENERATION MUTANTS P.T. 34; K.W. 0780000, 1002002, 0780020 bd National Eye Institute The

m o r t a l i t y f i g u r e s would i n d i c a t e , s i n c e many s t r o k e s are not f a t a l and r e c u r r e n t s t r o k e s are common i n n e a r l y a l l forms o f cerebrovascular d i s e a s e . I n t h e Black populat ion, age-adjusted dea th ra tes f o r s t r o k e are almost twice t h a t o f t h e white popula t ion . Dramatic d i f f e r e n c e s between t h e e x t e n t o f t h e va r ious cerebrovascular r i s k f a c t o r s are thought t o e x i s t among minor i ty popula t ions , when compared wi th each o the r , and when each is compared with t h e popula t ion as a whole. Whereas some r i s k f a c t o r s , such as t r a n s i e n t ischemic a t t a c k s , are wel l known, t h e e x i s t e n c e of

'-o t h e r f a c t o r s and t h e i n t e r r e l a t i o n s h i p between va r ious pred ispos ing f a c t o r s remain unc lea r . Not enough is known about d i f f e r e n c e s i n t h e incidence of t h e va r ious k inds o f s t roke , a l though c l i n i c a l evidence sugges ts t h a t such d i f f e r e n c e s maye x i s t .

RESEARCH GOALS AND SCOPE

The STP is seeking i n v e s t i g a t o r - i n i t i a t e d r e sea rch g ran t a p p l i c a t i o n s f o r bas i c ,app l i ed , and c l i n i c a l s t u d i e s r e l a t e d , i n t h e broadest sense, t o t h e e t i o l o g y ,prevent ion, e a r l y (presymptomatic) d i agnos i s , and t rea tment o f s t roke , inc ludingr e h a b i l i t a t i o n , as t h e s e may relate t o Blacks and o t h e r m i n o r i t i e s .

Examples o f important r e sea rch approaches f o r cons ide ra t ion might inc lude , bu t should n o t n e c e s s a r i l y be l i m i t e d t o r

o l o n g i t u d i n a l epidemiology o f t h e d i s t r i b u t i o n and i n t e r r e l a t i o n between r i s k f a c t o r s ;

o r e l a t i o n o f outcome from s t r o k e t o t h e d i f f e r e n c e s i n d i agnos t i cmethodology, acu te management, pos t - s t roke care, and r e c u r r e n t s t r o k e i n Blacks and o t h e r minor i t i e s ;

o eva lua t ion o f t rea tment f a c t o r s , inc luding t rea tment compliance, i n t h i s s p e c i a l populat ion;

o s p e c i a l problems o f Blacks and o t h e r m i n o r i t i e s t h a t may have an impact on t h e i d e n t i f i c a t i o n , d iagnos is , t r ea tmen t , management, follow-up, or long-term outcome;

o a p p l i c a t i o n and eva lua t ion o f emerging techniques f o r t h e a n a l y s i s ,d iagnos is , and t rea tment o f cerebrovascular d i sease ; and

o comparative s t u d i e s o f o t h e r i d e n t i f i a b l e popula t ions a t r i s k f o r s t r o k e .

MECHANISM OF SUPPORT

The support mechanism f o r g r a n t s i n t h i s area w i l l be t h e usua l i n v e s t i g a t o r - i n i t i a t e d r e sea rch p r o j e c t g ran t ( R o l l and t h e program p r o j e c t g ran t( P o l ) . Under t h e s e mechanisms, t h e p r i n c i p a l i n v e s t i g a t o r and any p a r t i c i p a t i n gi n v e s t i g a t o r s w i l l p lan , d i r e c t , and perform t h e r e sea rch . Applicants f o r programp r o j e c t g r a n t s should con tac t t h e NINCDS r e p r e s e n t a t i v e l i s t e d below as e a r l y as p o s s i b l e i n t h e planning stages.

APPLICATION AND REVIEW PROCEDURES

Appl ica t ions must be prepared on form PHS 398 according t o t h e i n s t r u c t i o n s included i n t h e a p p l i c a t i o n k i t . These k i t s are a v a i l a b l e from t h e bus iness o f f i c e s of most i n s t i t u t i o n s e l i g i b l e t o r ece ive Federal g r a n t s or from t h e Div is ion o f Research Grants, N I H . Appl icants f o r program p r o j e c t g r a n t s should r eques t , from t h e address below, a copy o f t h e NINCDS GUIDELINES FOR THE PREPARATION OF A PROGRAM PROJECT GRANT APPLICATION.

Receipt d a t e s f o r new re sea rch p r o j e c t g ran t ( R o l l a p p l i c a t i o n s and f o r programp r o j e c t g r a n t (PO11 a p p l i c a t i o n s are February 1, June 1, and October 1 .

On page 1 of form PHS 398, check "yes" i n i t e m 2 and type : "CEREBROVASCULAR DISEASE AND STROKE I N BLACKS AND OTHER MINORITIES."

U s e t h e mai l ing l a b e l provided i n t h e a p p l i c a t i o n k i t t o mail t h e s igned o r i g i n a land sFX exac t cop ie s o f it t o t h e Div is ion o f Research Grants .

6

Page 9: NIH Guide - Vol. 16, No. 10 - March 13, 1987 · 2014. 10. 3. · AVAILABILITY OF RETINAL DEGENERATION MUTANTS P.T. 34; K.W. 0780000, 1002002, 0780020 bd National Eye Institute The

If t h e a p p l i c a t i o n is f o r a program p r o j e c t g r a n t , p l ease send t h e o r i g i n a l and f o u r cop ies t o t h e Div is ion of Research Grants . Send two cop ies t o t h e addres s l i s t e d below. Any ques t ions concerning t h i s should be d i r e c t e d t o :

M s . Jean D . Benedict Health S c i e n t i s t Adminis t ra tor

\u~y' Stroke and Trauma Program, NINCDS Federal Bui lding, Room 8A13 7550 Wisconsin Avenue Bethesda, Maryland 20892 Telephone: ( 3 0 1 ) 496-4226

Research p r o j e c t g r a n t ( R o l l a p p l i c a t i o n s w i l l be reviewed f o r s c i e n t i f i c and t e c h n i c a l merit by an appropr i a t e s tudy s e c t i o n i n t h e Div is ion o f Research Grants. Program p r o j e c t g ran t (PO11 a p p l i c a t i o n s w i l l be reviewed by an appropr i a t e review group i n t h e NINCDS. Secondary review w i l l be by t h e Nat ional Advisory Neurologicaland Communicative Disorders and St roke Council . Appl ica t ions judged t o be wi th in t h e purview of o t h e r I n s t i t u t e s o f t h e N I H w i l l be ass igned accord ingly and, f o r t h e program p r o j e c t g r a n t a p p l i c a t i o n , reviewed according t o t h a t I n s t i t u t e ' s p r e v a i l i n gp r a c t i c e .

This program is descr ibed i n t h e Catalogue o f Federal Domestic Ass is tance , Number 13 .853 and 13 .854 , Stroke , Nervous System Trauma. Grants w i l l be awarded under t h e a u t h o r i t y of t h e Publ ic Heal th Serv ice A c t , T i t l e I V , Sec t ion 301 (Pub l i c Law 78-410, as amended: 42 USC 2 4 1 ) and adminis tered under PHS g r a n t p o l i c i e s and Federa l Regulat ions 42 CFR P a r t 52 and 45 CFR P a r t 7 4 . This program is no t s u b j e c tt o Heal th Se rv ices Agency review of t h e intergovernmental review requirementso f Executive Order 12372.

SMALL GRANT PROGRAM FOR PILOT PROJECTS

P.T. 3 4 , FF; K.W. 1002046, 07850359 0710030

National Eye I n s t i t u t e

The Nat ional Eye I n s t i t u t e (NE11 announces t h e r e v i s i o n o f its g u i d e l i n e s f o r small-grant awards, beginning with a p p l i c a t i o n s submit ted after t h e February 1, 1987 r e c e i p t d a t e . The p r i n c i p a l new f e a t u r e s o f t h e r ev i sed program g u i d e l i n e s inc lude t h e fol lowing:

\ m / "Target popula t ionsn of i n v e s t i g a t o r s f o r t h e program now inc lude ONLY t h e fo l lowingc a t e g o r i e s o f persons:

1 C l i n i c i a n s wi th l i m i t e d r e sea rch experience

2 I n v e s t i g a t o r s ( c l i n i c i a n s or non-c l in i c i ans ) coming i n t o v i s i o n r e sea rch for t h e first t i m e from another area

3 I n v e s t i g a t o r s a t minor i ty i n s t i t u t i o n s

4 I n v e s t i g a t o r s l o c a t e d i n l a rge ly non-research environments

5 Recently t r a i n e d b a s i c s c i e n t i s t s , who have rece ived t h e Ph.D. or o t h e r non-c l in ica l doc to ra t e wi th in t h e l as t 5 yea r s

The f irst two c a t e g o r i e s o f i n v e s t i g a t o r s w i l l be i n e s p e c i a l l y f avorab le p o s i t i o n sf o r funding of approved a p p l i c a t i o n s .

The maximum amount of an award w i l l be $25,000 ( d i r e c t c o s t s ) f o r a one-year per iod .

There w i l l be two r e c e i p t d a t e s f o r a p p l i c a t i o n s , which w i l l be accepted f o r review ONLY f o r February 1 and October 1 dead l ines each yea r .

TERMS OF THE AWARD

The award w i l l provide a maximum of $25,000 ( d i r e c t c o s t s ) f o r t e c h n i c a l assistance,supp l i e s , small equipment, and t r a v e l r equ i r ed by t h e p r o j e c t . The NE1 expec ts t o make approximately 15 awards f o r each review cyc le ( i . e . p 30 awards pe r y e a r ) .

The award may not be used t o supplement support for an ongoing projec t .

7

Page 10: NIH Guide - Vol. 16, No. 10 - March 13, 1987 · 2014. 10. 3. · AVAILABILITY OF RETINAL DEGENERATION MUTANTS P.T. 34; K.W. 0780000, 1002002, 0780020 bd National Eye Institute The

APPLICATION AND REVIEW PROCEDURES

App l i ca t ions s h a l l be submitted on form PHS 398, a v a i l a b l e a t most i n s t i t u t i o n a l bus iness o f f i c e s o r from t h e Divis ion o f Research Grants, N I H . Because t h e format f o r p repa r ing t h i s a p p l i c a t i o n is d i f f e r e n t from t h a t used f o r r e g u l a r r e sea rch g r a n t s , a d d i t i o n a l information and i n s t r u c t i o n s should be obtained from D r . Henleya t t h e addres s l i s t e d below. APPLICATIONS MUST ADHERE TO THIS FORMAT TO BE RESPONSIVE. Review w i l l be scheduled as fol lows:

Receipt Date I n s t i t u t e Committee Council Ear l ies t Date Annually Review Review f o r Funding

October 1 November Jan.-Feb. FebruaryFebruary 1 March May-June June

Approved a p p l i c a t i o n s w i l l e i t h e r be funded o r withdrawn immediately a f te r review byt h e Nat ional Advisory Eye Council .

REVIEW CRITERIA

App l i ca t ions w i l l be eva lua ted with r e s p e c t t o t h e fol lowing cr i ter ia : The s i g n i f i c a n c e and s c i e n t i f i c merit o f t h e proposed p r o j e c t ; i ts c h a r a c t e r i z a t i o n as an innovat ive and/or h igh - r i sk and/or p i l o t p r o j e c t which p rov ides a b a s i s for more extended r e sea rch ; t h e methodology, i nc lud ing choice o f experimental material; t h e i n v e s t i g a t o r ' s background and t r a i n i n g f o r c a r r y i n g out t h e p r o j e c t ; adequacy o f t h e a v a i l a b l e and requested f a c i l i t i e s and t h e adequacy o f j u s t i f i c a t i o n s p re sen ted f o r budget r e q u e s t s .

EENTERS FOR NEUROSCIENCE AND SCHIZOPHRENI A (CNSs)

P.T. 04; K.W. 1002030, 0710030, 0785185, 0414004

National I n s t i t u t e of Mental Heal th

App l i ca t ion Receipt Dates: October I , 1987 and February 1, 1988

The Nat ional I n s t i t u t e of Mental Health announces t h e a v a i l a b i l i t y o f support f o r Centers f o r Neuroscience and Schizophrenia (CNSs) t o pursue i n t e g r a t e d r e s e a r c h r e l e v a n t t o t h e schizophrenic d i s o r d e r s . It is expected t h a t t h e Centers w i l l encourage i n v e s t i g a t o r s t o b r i n g t o t h e f i e l d of c l i n i c a l schizophrenia r e sea rch t h e f u l l range o f e x p e r t i s e and advanced t echno log ie s a v a i l a b l e i n t h e b a s i c s c i e n c e s . The I n s t i t u t e expec t s t o make awards f o r two o r t h r e e Centers i n F i s c a l Year 1988,s u b j e c t t o t h e a v a i l a b i l i t y o f funds. Applicants are expected t o r eques t 5 y e a r s o f suppor t . The first r e c e i p t d a t e s f o r a p p l i c a t i o n s are October I , 1987, and February1, 1988; subsequently, a p p l i c a t i o n s w i l l be accepted on r e g u l a r l y scheduled r e c e i p tdead l ines . Letters o f ' in ten t are requested 6 months p r i o r t o t h e a p p l i c a t i o nr e c e i p t d a t e . Letters o f i n t e n t and i n q u i r i e s should be d i r e c t e d t o :

-

David Shore, M.D. Schizophrenia Research Branch Division of C l i n i c a l Research Room 1OC-06 Telephone: (301) 443-4707

Stephen Koslow, Ph.D. Neurosciences Research Branch Div i s ion o f Basic Sciences Room 11-105 Telephone : (301 1 443-1 504

The addres s f o r both o f t h e above is:

National I n s t i t u t e o f Mental Health Parklawn Building 5600 F i s h e r s Lane Rockvil le , Maryland 20857

o r

8

Page 11: NIH Guide - Vol. 16, No. 10 - March 13, 1987 · 2014. 10. 3. · AVAILABILITY OF RETINAL DEGENERATION MUTANTS P.T. 34; K.W. 0780000, 1002002, 0780020 bd National Eye Institute The

DEMENTIA ASSOCIATED WITH CEREBROVASCULAR DISEASE: ELUCIDATION OF MECHANISMS

P.T. 34; K.W. 0705010, 0745055, 0755030, 1002004, 0765035, 0745020

National I n s t i t u t e o f Neurological and Communicative Disorders and St roke

BACKGROUND

The St roke and Trauma Program o f t h e Nat ional I n s t i t u t e o f Neurological and Communicative Disorders and St roke (NINCDS) i n v i t e s g ran t a p p l i c a t i o n s f o r t h e support o f r e sea rch on t h e causa t ive mechanisms, prevent ion, and t rea tment o f dementia a s s o c i a t e d with cerebrovascular d i s e a s e . Although s t r o k e is t h e t h i r d l ead ing cause o f dea th and d i s a b i l i t y i n t h e United S t a t e s , t h e r e is a l s o a largenumber of v ic t ims of cerebrovascular d i s e a s e o r c e r e b r a l i n f a r c t i o n who experiencewidespread loss of neuro logica l func t ion t h a t may vary from minor memory loss t o d i f f u s e c e r e b r a l dysfunct ion but who do not show a t y p i c a l s t r o k e syndrome wi th t h e sudden onse t of f o c a l symptoms. The i n i t i a l complaint may be dementia with a s e v e r i t y t h a t depends upon t h e s t age , e x t e n t , o r anatomical s i t e of cerebrovascular d i s e a s e . The symptoms may inc lude minor f o c a l s igns , bu t t h e primary man i fe s t a t ion is a widespread loss of func t ion such as d i s o r i e n t a t i o n , loss o f motivat ion, apathy,i r r i t a b i l i t y , depress ion , loss of mental equi l ibr ium, and d e c l i n e o f memory o r s o c i a l withdrawal, a l l of which presumably r e s u l t from many small widespreadi n f a r c t i o n s t h a t i n d i v i d u a l l y cause only a s l i g h t d e t e r i o r a t i o n i n ove r t neuro logica l func t ion .

The u l t i m a t e o b j e c t i v e o f r e sea rch generated from t h i s program announcement is t o provide some form o f t rea tment e i t h e r t o prevent t h e d i s e a s e before it develops o r t o prevent progress ion once it has s t a r t e d . E f f e c t i v e t rea tment , however, must be based on accu ra t e d i agnos i s and t h e e l u c i d a t i o n o f t h e phys io log ica l , molecular, and c e l l u l a r causes o f t h e d i s e a s e .

RESEARCH GOALS AND SCOPE

Dementia a s s o c i a t e d with cerebrovascular d i s e a s e may i n i t i a l l y be c l i n i c a l l y similar t o dementia from o t h e r causes . Consequently, f o r purposes o f s tudying t h e phys io log ica l , biochemical, and molecular causes o f cerebrovascular dementia, as w e l l as means o f prevent ion, i n t e rven t ion , t rea tment , o r poss ib ly even r e v e r s a l o f dementia secondary t o cerebrovascular d i sease , it is e s s e n t i a l t h a t phys ic ians and s c i e n t i s t s be a b l e t o d i s t i n g u i s h between dementia a s soc ia t ed with cerebrovascular d i s e a s e and dementia o f o t h e r e t i o l o g i e s . Thus, g ran t a p p l i c a t i o n s are i n v i t e d on

hd t o p i c s t h a t may range from fundamental r e sea rch ( s t u d i e s o f bas i c , mechanis t ic causes) t o t h e e s s e n t i a l a s p e c t s o f d i agnos i s and t h e r a p e u t i c moda l i t i e s . I n a d d i t i o n t o unresolved i s s u e s and problems t h a t need t o be enunciated, def ined , and explored, t h e fo l lowing examples inc lude but are not l i m i t e d t o s p e c i f i c r e sea rch ques t ions t h a t may be addressed.

o What s c i e n t i f i c a l l y sound and meaningful d i s t i n c t i o n s can be made between t h e dementia caused by mul t ip l e c e r e b r a l i n fa rc t s and dementias of o t h e r e t i o l o g i e s ?

o What are t h e vascu la r , anatomical, phys io log ica l , c e l l u l a r , and molecular events t h a t l e a d t o t h e cerebrovascular d i s e a s e t h a t r e s u l t s i n dementia and how may t h e s e even t s be measured?

o A r e t h e r e anatomical , phys io logica l , c e l lu l a r , and ( o r ) molecular markers or events t h a t can be used as p r e d i c t o r s f o r developing and guid ing d i agnos i s and t rea tment o r t h a t can serve as i n d i c a t o r s f o r c o n t r o l l i n g t h e development or progress ion o f dementia a s soc ia t ed wi th cerebrovascular d i sease?

o A r e t h e r e d i f f e r e n t t ypes o f cerebrovascular d i s e a s e t h a t cause dementia? If so, how can they be d i s t ingu i shed phys io log ica l ly , c l i n i c a l l y , o r pa tho log ica l ly? Is t h e outcome d i f f e r e n t ?

MECHANISM OF SUPPORT

The support mechanisms f o r g r a n t s i n t h i s area w i l l be t h e t r a d i t i o n a l i n v e s t i g a t o r - i n i t i a t e d r e sea rch p r o j e c t g r a n t (Rol l and t h e program p r o j e c t g r a n t( P o l ) . Under t h e s e mechanisms, t h e p r i n c i p a l i n v e s t i g a t o r and any p a r t i c i p a t i n gi n v e s t i g a t o r s w i l l p lan, d i r e c t , and perform t h e r e sea rch . P o t e n t i a l a p p l i c a n t s f o r program p r o j e c t g r a n t s should con tac t t h e NINCDS r e p r e s e n t a t i v e l i s t e d below as e a r l y as p o s s i b l e i n t h e planning s t a g e s f o r advice and guidance.

9

Page 12: NIH Guide - Vol. 16, No. 10 - March 13, 1987 · 2014. 10. 3. · AVAILABILITY OF RETINAL DEGENERATION MUTANTS P.T. 34; K.W. 0780000, 1002002, 0780020 bd National Eye Institute The

APPLICATION AND REVIEW PROCEDURES

Applicat ion must be prepared on form PHS 398 according t o t h e a p p l i c a b l e i n s t r u c t i o n s included i n t h e a p p l i c a t i o n k i t . These k i t s are a v a i l a b l e from t h e bus iness o f f i c e s o f most i n s t i t u t i o n s e l i a i b l e t o r e c e i v e Federal a r a n t s o r from t h e Division o f Research Grants, N I H . Appl icants f o r program p r o j e c t g r a n t s should r e q u e s t , from t h e addres s below, a copy o f t h e NINCDS GUIDELINES FOR THE PREPARATION .-OF A PROGRAM PROJECT GRANT APPLICATION.

Receipt d a t e s f o r new re sea rch p r o j e c t g r a n t ( R o l l a p p l i c a t i o n s and f o r programp r o j e c t g r a n t (PO11 a p p l i c a t i o n s are February 1, June 1 , and October 1 .

On page 1 o f form PHS 398, check "yes" i n i t e m 2 and type : "DEMENTIA ASSOCIATED WITH CEREBROVASCULAR DISEASE: ELUCIDATION OF MECHANISMS."

U s e t h e mail ing l a b e l provided i n t h e a p p l i c a t i o n k i t t o mail t h e s igned o r i g i n a l and s i x exact c o p i e s o f it t o t h e Divis ion o f Research Grants ( D R G ) . If t h e a p p l i c a t i o n is f o r a program p r o j e c t g r a n t , p l e a s e send t h e o r i g i n a l and 4 cop ie s t o DRG. The o t h e r 2 cop ie s should be s e n t t o :

Jean D . Benedict Health S c i e n t i s t Adminis t ra tor St roke and Trauma Program, NINCDS Federal Building, Room 8A-13 Bethesda, Maryland 20892 Telephone: (301) 496-4226

Research p r o j e c t g r a n t (Rol l a p p l i c a t i o n s w i l l be reviewed f o r s c i e n t i f i c and t e c h n i c a l merit by an a p p r o p r i a t e s tudy s e c t i o n i n t h e Divis ion o f Research Grants . Program p r o j e c t g r a n t (PO11 a p p l i c a t i o n s w i l l be reviewed by an a p p r o p r i a t e review group i n t h e NINCDS. Secondary review w i l l be by t h e Nat ional Advisory Neurological and Communicative Disorders and S t roke Council . App l i ca t ions judged t o be wi th in t h e purview o f o t h e r I n s t i t u t e s o f t h e N I H w i l l be ass igned accordingly, and, f o r t h e program project grant a p p l i c a t i o n , reviewed according t o t h a t I n s t i t u t e ' s p r e v a i l i n g p r a c t i c e .

T h i s program is desc r ibed i n t h e Catalogue o f Federal Domestic Ass i s t ance , Number 13.853 and 13.854, Stroke, Nervous System Trauma. Grants w i l l be awarded under t h e a u t h o r i t y o f t h e Pub l i c Heal th Se rv ice Act, T i t l e I V , Sec t ion 301 (Pub l i c Law 78-410, as amended: 42 USC 241) and adminis tered under PHS g r a n t p o l i c i e s and Federal Regulat ions 42 CFR P a r t 52 and 45 CFR P a r t 74. This program is not s u b j e c t -t o t h e intergovernmental review requirements o f Executive Order 12372 o r t o review by a Heal th Systems Agency.

ERRATUM

JJ

P.T. 34, 11; K.W. 0770000, 1014002

National i n s t i t u t e s of Health Alcohol, Drug Abuse, and Mental Heal th Adminis t ra t ion

The above-referenced Notice publ ished i n t h e N I H Guide f o r Grants and Con t rac t s , Vol. 16, No. 3, da t ed January 23, 1987, has an e r r o r i n t h e t h i r d sentence of t h e second paragraph. The sentence should r ead as fo l lows :

"Gender d i f f e r e n c e s should be noted and evaluated."

1:

10 0 U . S . G.P.O. 1987-181-289:40035